Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2023 Mar 1;133(5):e169500. doi: 10.1172/JCI169500

IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury

Shiqin Xiong, Zhigang Hong, Long Shuang Huang, Yoshikazu Tsukasaki, Saroj Nepal, Anke Di, Ming Zhong, Wei Wu, Zhiming Ye, Xiaopei Gao, Gadiparthi N Rao, Dolly Mehta, Jalees Rehman, Asrar B Malik
PMCID: PMC9974088  PMID: 36856118

Original citation: J Clin Invest. 2020;130(7):3684–3698. https://doi.org/10.1172/JCI136908

Citation for this corrigendum: J Clin Invest. 2023;133(5):e169500. https://doi.org/10.1172/JCI169500

In the original version of Figure 4D, the representative lung histology sections of control and LPS-exposed animals, specifically the Rolipram (5 mg/kg)/PBS, Rolipram (5 mg/kg)/LPS, Rolipram (10 mg/kg)/PBS, and Rolipram (10 mg/kg)/LPS samples, inadvertently showed overlapping images from the same slide due to an error in figure assembly. The correct figure is shown below.

graphic file with name jci-133-169500-g157.jpg

The authors regret the error.

Version 1. 03/01/2023

Electronic publication

Footnotes


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES